Cindy Paradiso is an assistant professor at Pace Universitys Lienhard School of Nursing in the College of Health Professions in Pleasantville, New York, and a clinical quality specialist at White Plains Hospital in White Plains, New York
A chronic treatment for a chronic disease
Participants who took semaglutide didnt just drink less alcohol
Specifically, study participants taking GLP-1 drugs had a 10% lower risk of depression than participants taking DPP4i medication
Reconstitution and handling
The GLP-1 receptor agonists included dulaglutide (Trulicity, Eli Lilly), liraglutide (Saxenda, Novo Nordisk), exenatide (Bydureon, AstraZeneca), tirzepatide (Zepbound, Eli Lilly) and semaglutide